NCT00287898View on ClinicalTrials.gov

Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 Mutation

NACompletedINTERVENTIONAL
Enrollment

669

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2014

Conditions
Breast Cancer
Interventions
BEHAVIORAL

Telephone Genetic Counseling

Participants will receive all genetic counseling via telephone

BEHAVIORAL

Usual Care

subjects will receive standard in-person genetic counseling

Trial Locations (4)

10029

Mount Sinai School of Medicine, New York

20007

Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C.

02115-6084

Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute, Boston

05405-0110

Vermont Cancer Center at University of Vermont, Burlington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Georgetown University

OTHER

NCT00287898 - Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 Mutation | Biotech Hunter | Biotech Hunter